From major journals, first or last author from the Institute for Cancer Research
Ullern A, Holm K, Røssevold AH, Andresen NK, Bang C, Lingjærde OC, Naume B, Hov JR, Kyte JA(2024) Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13760, PubMed 39545921
Pankiv S, Dahl AK, Aas A, Andersen RL, Brech A, Holland P, Singh S, Bindesbøll C, Simonsen A(2024) BEACH domain proteins function as cargo-sorting adaptors in secretory and endocytic pathways J Cell Biol, 223(12) DOI 10.1083/jcb.202408173, PubMed 39514288
Demir MF, Lin YH, Costa Cruz PH, Tajima M, Honjo T, Müller E(2024) Blocking S100A9-signaling is detrimental to the initiation of anti-tumor immunity Front Immunol, 15, 1479502 DOI 10.3389/fimmu.2024.1479502, PubMed 39497822
Ankill J, Zhao Z, Tekpli X, Kure EH, Kristensen VN, Mathelier A, Fleischer T(2024) Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation PLoS Comput Biol, 20(11), e1012565(in press) DOI 10.1371/journal.pcbi.1012565, PubMed 39556603
Kiviaho A, Eerola SK, Kallio HML, Andersen MK, Hoikka M, Tiihonen AM, Salonen I, Spotbeen X, Giesen A, Parker CTA, Taavitsainen S, Hantula O, Marttinen M, Hermelo I, Ismail M, Midtbust E, Wess M, Devlies W, Sharma A, Krossa S, Häkkinen T, Afyounian E, Vandereyken K, Kint S, Kesseli Jet al.(2024) Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer Nat Commun, 15(1), 9949 DOI 10.1038/s41467-024-54364-1, PubMed 39550375
Ullern A, Holm K, Røssevold AH, Andresen NK, Bang C, Lingjærde OC, Naume B, Hov JR, Kyte JA(2024) Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13760, PubMed 39545921